A US Food and Drug Administration perspective on evaluating medical products for Ebola

被引：9
|
作者：
Russek-Cohen, Estelle [1 ]
Rubin, Daniel [2 ]
Price, Dionne [2 ]
Sun, Wellington [1 ]
Cox, Edward [2 ]
Borio, Luciana [3 ]
机构：
[1] US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
[2] US FDA, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
[3] US FDA, Off Commissioner, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
来源：
CLINICAL TRIALS | 2016年 / 13卷 / 01期
关键词：
Therapeutic clinical trials; vaccine clinical trials; Ebola; SIERRA-LEONE; VACCINE; TRIALS;
D O I：
10.1177/1740774515620613
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：105 / 109
页数：5
相关论文
共 50 条
  • [21] The Food and Drug Administration and pragmatic clinical trials of marketed medical products
    Anderson, Monique L.
    Griffin, Joseph
    Goldkind, Sara F.
    Zeitler, Emily P.
    Wing, Liz
    Al-Khatib, Sana M.
    Sherman, Rachel E.
    CLINICAL TRIALS, 2015, 12 (05) : 511 - 519
  • [22] Comorbid mood disorders and medical illness: A food and drug administration perspective
    Laughren, TP
    BIOLOGICAL PSYCHIATRY, 2003, 54 (03) : 195 - 199
  • [23] US Food and Drug Administration Regulation of Tobacco Products Time for a Course Correction
    Farber, Harold J.
    Neptune, Enid
    Ewart, Gary
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (01) : 44 - 48
  • [24] US FOOD AND DRUG ADMINISTRATION ISSUES FINAL RULE ON ALL TOBACCO PRODUCTS
    Garvin, Jennifer
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2016, 147 (07): : 535 - 535
  • [25] Tutorial on How the US Food and Drug Administration Regulates Parenteral Nutrition Products
    Tabor, Edward
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2020, 44 (02) : 174 - 181
  • [26] Compromise or Capitulation? US Food and Drug Administration Jurisdiction Over Tobacco Products
    Glantz, Stanton A.
    Barnes, Richard
    Eubanks, Sharon Y.
    PLOS MEDICINE, 2009, 6 (07)
  • [27] US Food and Drug Administration regulations governing label claims for food products, including probiotics
    Saldanha, Leila G.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 : S119 - S121
  • [28] US Food and Drug Administration Updates
    Sahin, L.
    BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 748 - 748
  • [29] Transparency at the US Food and Drug Administration
    Califf, Robert M.
    JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 24 - 28
  • [30] Independence at the US Food and Drug Administration
    不详
    LANCET, 2006, 367 (9523): : 1630 - 1630
12345